Pancreatic Cancer Research

ResearcherJinan UniversityActive in the last 2 years

Shiye Ruan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8304-0168; OpenAlex author ID A5103954675. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 8

  1. Multi-omics analysis identifies PUS7 as an immune modulator driving NETs-mediated macrophage polarization in pancreatic cancer. First author DOI 10.1002/ctm2.70581↗
  2. LINC00476 cooperates with ARIH2 and suppresses pancreatic cancer progression by inducing VIM ubiquitination. Co-author DOI 10.1097/js9.0000000000003596↗
  3. A Preoperative Model for Predicting Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.jss.2025.06.081↗
  4. Prognostic significance of glucose-lipid metabolic index in pancreatic cancer patients with diabetes mellitus. First author DOI 10.1002/cam4.7108↗
  5. Identification and validation of stemness-based and ferroptosis-related molecular clusters in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.tranon.2024.101877↗
  6. Score for predicting overall survival in pancreatic adenocarcinoma patients with positive lymph nodes after surgery: a novel nomogram-based risk assessment. Co-author DOI 10.21037/gs-20-597↗
  7. The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.1186/s13014-020-01511-9↗
  8. Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2019.00773↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baohua Hou · 6 shared papers, 2019–2026 · strength 1.19
  2. Chuanzhao Zhang · 4 shared papers, 2024–2026 · strength 0.98
  3. Shanzhou Huang · 4 shared papers, 2024–2026 · strength 0.98
  4. Jike Fang · 2 shared papers, 2026 · strength 0.56
  5. Yiping Zou · 3 shared papers, 2020–2025 · strength 0.54
  6. Zhongyan Zhang · 2 shared papers, 2024 · strength 0.42
  7. Hailiang Wang · 2 shared papers, 2024 · strength 0.42
  8. Haosheng Jin · 3 shared papers, 2019–2021 · strength 0.35
  9. Song Gao · 1 shared paper, 2025 · strength 0.28
  10. Yuexiang Liang · 1 shared paper, 2025 · strength 0.28
  11. Zhenchong Li · 1 shared paper, 2026 · strength 0.26
  12. Qian Yan · 1 shared paper, 2026 · strength 0.26
  13. Ning Shi · 2 shared papers, 2020–2021 · strength 0.26
  14. Liang Jin · 2 shared papers, 2020–2021 · strength 0.26
  15. Zhixiang Jian · 2 shared papers, 2019–2020 · strength 0.21
  16. Qi Zhou · 1 shared paper, 2024 · strength 0.21
  17. Zelong Wu · 1 shared paper, 2024 · strength 0.21
  18. Min Yu · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.